Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HI-PEITHO: Ultrasound-facilitated Thrombolysis vs Anticoagulation for Acute Pulmonary Embolism
NCT04790370Phase 4Active, not recruiting
- Sponsor
- Boston Scientific Corporation
- Start
- Aug 2021
- Primary completion
- Jul 2025
- Countries
- 9
01
Overview
Phase 4, randomised, open-label trial in pulmonary embolism (PE) (2 arms), sponsored by Boston Scientific Corporation. Primary endpoints: Pulmonary Embolism-related mortality at 7 days, Pulmonary Embolism recurrence at 7 days and 1 more. Started Aug 2021; status: active, not recruiting.
02
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04790370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04790370.